{
      "DOI":"10.1101/2020.09.14.20194308",
      "type":"preprint",
      "published": "2020-09-18",
      "journal": {
          "title": "medRxiv"
          },
      "title":"Antibodies to SARS-CoV-2 and risk of future sickness",
      "authors":[
      {
         "given":"Joakim",
         "family":"Dillner",
         "sequence":"first",
         "affiliation":[

         ]
      },
      {
         "given":"Miriam",
         "family":"Elfstr\u00f6m",
         "sequence":"additional",
         "affiliation":[

         ]
      },
      {
         "given":"Jonas",
         "family":"Blomqvist",
         "sequence":"additional",
         "affiliation":[

         ]
      },
      {
         "given":"Carina",
         "family":"Eklund",
         "sequence":"additional",
         "affiliation":[

         ]
      },
      {
         "given":"Camilla",
         "family":"Lagheden",
         "sequence":"additional",
         "affiliation":[

         ]
      },
      {
         "given":"Sara",
         "family":"Nordqvist-Kleppe",
         "sequence":"additional",
         "affiliation":[

         ]
      },
      {
         "given":"Cecilia",
         "family":"Hellstr\u00f6m",
         "sequence":"additional",
         "affiliation":[

         ]
      },
      {
         "given":"Jennie",
         "family":"Olofsson",
         "sequence":"additional",
         "affiliation":[

         ]
      },
      {
         "given":"Eni",
         "family":"Andersson",
         "sequence":"additional",
         "affiliation":[

         ]
      },
      {
         "given":"August",
         "family":"Jernbom Falk",
         "sequence":"additional",
         "affiliation":[

         ]
      },
      {
         "given":"Sofia",
         "family":"Bergstr\u00f6m",
         "sequence":"additional",
         "affiliation":[

         ]
      },
      {
         "given":"Emilie",
         "family":"Hultin",
         "sequence":"additional",
         "affiliation":[

         ]
      },
      {
         "given":"Elisa",
         "family":"Pin",
         "sequence":"additional",
         "affiliation":[

         ]
      },
      {
         "given":"Anna",
         "family":"M\u00e5nberg",
         "sequence":"additional",
         "affiliation":[

         ]
      },
      {
         "given":"Peter",
         "family":"Nilsson",
         "sequence":"additional",
         "affiliation":[

         ]
      },
      {
         "given":"My",
         "family":"Hedhammar",
         "sequence":"additional",
         "affiliation":[

         ]
      },
      {
         "given":"Sophia",
         "family":"Hober",
         "sequence":"additional",
         "affiliation":[

         ]
      },
      {
         "given":"Johan",
         "family":"Mattsson",
         "sequence":"additional",
         "affiliation":[

         ]
      },
      {
         "given":"Laila Sara",
         "family":"Arroyo M\u00fchr",
         "sequence":"additional",
         "affiliation":[

         ]
      },
      {
         "given":"Kalle",
         "family":"Conneryd Lundgren",
         "sequence":"additional",
         "affiliation":[

         ]
      }
      ],
      "abstract": "Background: The extent that antibodies to SARS-CoV-2 may protect against future virus-associated disease is unknown. Method: We analyzed 12928 healthy hospital employees for SARS-CoV-2 antibodies and compared results to participant sick leave records (Clinical trial registration: ClinicalTrials.gov). Results: Subjects with viral serum antibodies were not at excess risk for future sick leave (Odds Ratio (OR): 0.85 (95% Confidence Interval (CI) (0.85 (0.43-1.68)). By contrast, subjects with antibodies had an excess risk for sick leave in the past weeks (OR: 3.34 (2.98-3.74)). Conclusion: Presence of viral antibodies marks past disease and protection against excess risk of future disease.",
      "data": [{
        "description": "Pseudonymised, individual-level data available on request."
      }]
   }
}
